Ascendis Pharma A/S (ASND)

Ascendis Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Market Capitalization	14,444	13,089	8,234	7,125	6,824	7,635
Market Cap Growth	107.70%	58.97%	15.57%	4.41%	-10.63%	-15.23%
Enterprise Value	14,724	13,411	8,416	7,347	6,449	6,676
Last Close Price	234.99	213.24	137.67	125.95	122.13	134.53
Forward PE	42.86	94.73	-	-	-	-
PS Ratio	17.06	15.48	21.87	24.17	124.77	863.17
PB Ratio	-	-68.47	-75.24	-44.24	24.25	7.60
P/TBV Ratio	-	-	-	-	24.70	7.64
P/FCF Ratio	269.50	245.48	-	-	-	-
P/OCF Ratio	227.93	206.83	-	-	-	-
EV/Sales Ratio	17.41	15.86	22.35	24.92	117.92	754.73
EV/FCF Ratio	275.11	251.52	-	-	-	-
Debt / Equity Ratio	-5.35	-5.35	-8.10	-4.42	1.93	0.12
Debt / FCF Ratio	19.20	19.20	-	-	-	-
Net Debt / Equity Ratio	-1.57	-1.57	-2.81	-1.68	-0.89	-0.77
Net Debt / EBITDA Ratio	-1.95	-1.95	-1.08	-0.56	0.43	1.57
Net Debt / FCF Ratio	5.63	5.63	-0.97	-0.52	0.46	1.55
Asset Turnover	0.58	0.58	0.36	0.28	0.05	0.01
Inventory Turnover	0.32	0.32	0.18	0.26	0.12	-
Quick Ratio	0.72	0.72	0.81	0.62	1.06	7.03
Current Ratio	1.04	1.04	1.17	0.95	1.29	8.03
Return on Equity (ROE)	-	-	-	-818.43%	-101.69%	-44.54%
Return on Assets (ROA)	-6.86%	-6.86%	-17.38%	-29.73%	-32.29%	-27.35%
Return on Capital Employed (ROCE)	-58.40%	-58.40%	-102.60%	-511.40%	-150.60%	-45.90%
Earnings Yield	-1.86%	-2.05%	-4.75%	-7.47%	-9.13%	-5.71%
FCF Yield	0.37%	0.41%	-3.87%	-7.29%	-7.99%	-6.57%
Buyback Yield / Dilution	-4.69%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q